Gábor Késmárky
About
In The Last Decade
Gábor Késmárky
55 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 134
- Pulmonary and Respiratory Medicine 446
- Cardiology and Cardiovascular Medicine 403
- Surgery 203
- Physiology 184
- Endocrinology, Diabetes and Metabolism 159
Countries citing papers authored by Gábor Késmárky
This map shows the geographic impact of Gábor Késmárky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gábor Késmárky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gábor Késmárky more than expected).
Fields of papers citing papers by Gábor Késmárky
This network shows the impact of papers produced by Gábor Késmárky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gábor Késmárky. The network helps show where Gábor Késmárky may publish in the future.
Co-authorship network of co-authors of Gábor Késmárky
This figure shows the co-authorship network connecting the top 25 collaborators of Gábor Késmárky. A scholar is included among the top collaborators of Gábor Késmárky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gábor Késmárky. Gábor Késmárky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 4 | |
| 4 | 0 | |
| 5 | The Role of Adjuvant Vinpocetine Therapy in Aspirin-Treated Cerebrovascular Patients | 2 |
| 6 | 13 | |
| 7 | 7 | |
| 8 | 3 | |
| 9 | 23 | |
| 10 | 8 | |
| 11 | Low hematocrit per blood viscosity ratio as a mortality risk factor in coronary heart disease. | 22 |
| 12 | 242 | |
| 13 | 52 | |
| 14 | 37 | |
| 15 | 10 | |
| 16 | 43 | |
| 17 | 83 | |
| 18 | 10 | |
| 19 | 27 | |
| 20 | Red blood cell aggregation measurements in whole blood and in fibrinogen solutions by different methods. | 42 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.